An experimental study has shown the beneficial effects (inhibition of ALI, decrease in pro-inflammatory cytokines levels, and decrease in the mortality) of resveratrol during K. pneumoniae-induced pneumonia through the NLRP3 inflammasome inhibition (100). The gene discussed is NLRP3; the disease is pneumonia.